Overall, tailoring an HIV treatment regimen to individuals’ clinical and social context can help mitigate the persistent barriers to care access. Switching treatment is not just a clinical decision ...

IN SHORT: Viral posts circulating on Facebook in Kenya and Tanzania claim to show HIV magnified under a microscope, suggesting the virus's anatomy makes it drug-resistant. But the image actually shows ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

Researchers used cryo-EM to study how the HIV enzyme integrase arranges in 3D to slip its DNA into the host genome and pack ...

Salk Institute researchers determine the structure of HIV protein during a newly discovered function, enabling the ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV ...

Early broadly neutralising antibody responses against the E1E2 glycoprotein seem to be important for preventing persistence ...

Scientists in Germany have made a breakthrough that could become important in HIV research. They’ve identified a single ...

SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to undetectable levels. As a result, by taking a single daily dose of an ...